125 related articles for article (PubMed ID: 9687337)
1. Association of halofantrine with postprandially derived plasma lipoproteins decreases its clearance relative to administration in the fasted state.
Humberstone AJ; Porter CJ; Edwards GA; Charman WN
J Pharm Sci; 1998 Aug; 87(8):936-42. PubMed ID: 9687337
[TBL] [Abstract][Full Text] [Related]
2. The influence of lipids on stereoselective pharmacokinetics of halofantrine: Important implications in food-effect studies involving drugs that bind to lipoproteins.
Brocks DR; Wasan KM
J Pharm Sci; 2002 Aug; 91(8):1817-26. PubMed ID: 12115809
[TBL] [Abstract][Full Text] [Related]
3. Differences in the lipoprotein binding profile of halofantrine in fed and fasted human or beagle plasma are dictated by the respective masses of core apolar lipoprotein lipid.
McIntosh MP; Porter CJ; Wasan KM; Ramaswamy M; Charman WN
J Pharm Sci; 1999 Mar; 88(3):378-84. PubMed ID: 10052998
[TBL] [Abstract][Full Text] [Related]
4. Differences in the lipoprotein distribution of halofantrine are regulated by lipoprotein apolar lipid and protein concentration and lipid transfer protein I activity: in vitro studies in normolipidemic and dyslipidemic human plasmas.
Wasan KM; Ramaswamy M; McIntosh MP; Porter CJ; Charman WN
J Pharm Sci; 1999 Feb; 88(2):185-90. PubMed ID: 9950636
[TBL] [Abstract][Full Text] [Related]
5. Effect of altered serum lipid concentrations on the IC50 of halofantrine against Plasmodium falciparum.
Humberstone AJ; Cowman AF; Horton J; Charman WN
J Pharm Sci; 1998 Feb; 87(2):256-8. PubMed ID: 9519163
[TBL] [Abstract][Full Text] [Related]
6. A physicochemical basis for the effect of food on the absolute oral bioavailability of halofantrine.
Humberstone AJ; Porter CJ; Charman WN
J Pharm Sci; 1996 May; 85(5):525-9. PubMed ID: 8742945
[TBL] [Abstract][Full Text] [Related]
7. A conscious dog model for assessing the absorption, enterocyte-based metabolism, and intestinal lymphatic transport of halofantrine.
Khoo SM; Edwards GA; Porter CJ; Charman WN
J Pharm Sci; 2001 Oct; 90(10):1599-607. PubMed ID: 11745718
[TBL] [Abstract][Full Text] [Related]
8. Effect of micronized fenofibrate on plasma lipoprotein levels and hemostatic parameters of hypertriglyceridemic patients with low levels of high-density lipoprotein cholesterol in the fed and fasted state.
Genest J; Nguyen NH; Theroux P; Davignon J; Cohn JS
J Cardiovasc Pharmacol; 2000 Jan; 35(1):164-72. PubMed ID: 10630748
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of halofantrine to its equipotent metabolite, desbutylhalofantrine, is decreased when orally administered with ketoconazole.
Khoo SM; Porter JH; Edwards GA; Charman WN
J Pharm Sci; 1998 Dec; 87(12):1538-41. PubMed ID: 10189263
[TBL] [Abstract][Full Text] [Related]
10. Intravenous dosing conditions may affect systemic clearance for highly lipophilic drugs: implications for lymphatic transport and absolute bioavailability studies.
Caliph SM; Trevaskis NL; Charman WN; Porter CJ
J Pharm Sci; 2012 Sep; 101(9):3540-6. PubMed ID: 22623170
[TBL] [Abstract][Full Text] [Related]
11. Influence of physicochemical properties on the patterns of association of a series of aliphatic esters of halofantrine with plasma lipoproteins.
McIntosh MP; Charman WN; Campbell M; Porter CJ
J Control Release; 2004 Mar; 95(2):275-89. PubMed ID: 14980776
[TBL] [Abstract][Full Text] [Related]
12. A physicochemical basis for the extensive intestinal lymphatic transport of a poorly lipid soluble antimalarial, halofantrine hydrochloride, after postprandial administration to dogs.
Khoo SM; Prankerd RJ; Edwards GA; Porter CJ; Charman WN
J Pharm Sci; 2002 Mar; 91(3):647-59. PubMed ID: 11920750
[TBL] [Abstract][Full Text] [Related]
13. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of halofantrine in man: effects of food and dose size.
Milton KA; Edwards G; Ward SA; Orme ML; Breckenridge AM
Br J Clin Pharmacol; 1989 Jul; 28(1):71-7. PubMed ID: 2775616
[TBL] [Abstract][Full Text] [Related]
15. Minor components of olive oil facilitate the triglyceride clearance from postprandial lipoproteins in a polarity-dependent manner in healthy men.
Cabello-Moruno R; Martinez-Force E; Montero E; Perona JS
Nutr Res; 2014 Jan; 34(1):40-7. PubMed ID: 24418245
[TBL] [Abstract][Full Text] [Related]
16. Enhanced oral absorption of halofantrine enantiomers after encapsulation in a proliposomal formulation.
Brocks DR; Betageri GV
J Pharm Pharmacol; 2002 Aug; 54(8):1049-53. PubMed ID: 12195818
[TBL] [Abstract][Full Text] [Related]
17. Plasma lipoprotein distribution of apolipoprotein(a) in the fed and fasted states.
Cohn JS; Lam CW; Sullivan DR; Hensley WJ
Atherosclerosis; 1991 Sep; 90(1):59-66. PubMed ID: 1799398
[TBL] [Abstract][Full Text] [Related]
18. The effect of experimental hyperlipidemia on the stereoselective tissue distribution, lipoprotein association and microsomal metabolism of (+/-)-halofantrine.
Patel JP; Fleischer JG; Wasan KM; Brocks DR
J Pharm Sci; 2009 Jul; 98(7):2516-28. PubMed ID: 18972574
[TBL] [Abstract][Full Text] [Related]
19. Effects of increasing doses of simvastatin on fasting lipoprotein subfractions, and the effect of high-dose simvastatin on postprandial chylomicron remnant clearance in normotriglyceridemic patients with premature coronary sclerosis.
van Wijk JP; Buirma R; van Tol A; Halkes CJ; De Jaegere PP; Plokker HW; van der Helm YJ; Castro Cabezas M
Atherosclerosis; 2005 Jan; 178(1):147-55. PubMed ID: 15585212
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin improves postprandial lipoprotein metabolism in normolipidemlic subjects.
Parhofer KG; Barrett PH; Schwandt P
J Clin Endocrinol Metab; 2000 Nov; 85(11):4224-30. PubMed ID: 11095458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
